Kathryn is a senior associate with a corporate, regulatory and public policy practice, primarily focused on the health sector.
Corporate & Board Governance
Kathryn advises charitable, not-for-profit and for-profit entities on a broad range of corporate matters. She routinely provides advice on board governance matters, including on by-laws, policies and board education. She advises on legal requirements and good governance practices relating to fiduciary duties, conflicts of interest, and board recruitment and diversity. She drafts agreements and memoranda of understanding, including for services, donations and sponsorship arrangements.
Kathryn provides advice on health system integrations and other transactions, including amalgamations, shared service arrangements and alliances. In addition, she is knowledgeable on the legal and strategic considerations for establishing ancillary businesses, social enterprises and mission-related investments.
Regulatory, Public Policy & Ethics
In addition to her corporate practice, Kathryn provides advice on a range of health regulatory and public policy matters. She advises healthcare providers and drug and medical device companies on managing and avoiding conflict of interests and has drafted regulations and by-laws for self-governing regulatory colleges.
Kathryn has worked with various health sector entities and government agencies on governance models and accountability, including a regional initiative to coordinate seniors’ care service delivery and a regional electronic health record project. In 2013, she led the legal research contribution for the Institute of Public Administration’s report on Healthcare Governance Models in Canada. She frequently publishes and speaks on topical issues in health law, policy and governance.
Kathryn is also well-versed in broader public sector transparency and accountability laws, and other ethics-related laws.
Kathryn is currently based out of the firm’s London, UK office. From London, she continues to serve Canadian clients as well as providing support to UK-based and other entities who may be interested in investing in Canadian healthcare.